Evotec SEEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 3.452 EUR | 7,3 EUR | 3,176 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 177.694.559 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Evotec SE
Mitarbeiter 4.526
Handelsplatz XETRA
Ticker Symbol EVT
IPO Datum -
Adresse Essener Bogen 7, Hamburg, Germany, 22419
Webseite https://www.evotec.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Christian Wojczewski Ph.D. | CEO & Chairperson of the Management Board |
| 2 | Dr. Cord Dohrmann Ph.D. | Chief Scientific Officer & Member of Management Board |
| 3 | Ms. Aurelie Dalbiez | Chief People Officer & Member of Management Board |
| 4 | Ms. Claire Hinshelwood | CFO & Member of Management Board |
| 5 | Dr. Ingrid Mller | COO & Member of Management Board |
| 6 | Dr. Sarah Fakih | Executive VP, Head of Global Communications & Investor Relations |
| 7 | Dr. Christian Dargel | EVP Global Head of Legal & Compliance |
| 8 | Dr. Ian M. Hunneyball | Senior Vice President of Programme Management & Clinical Operations |
| 9 | Dr. David Hallet | Executive Vice President |
| 10 | Uwe Andag | EVP Head of Metabolic Diseases |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.